FR2411412A1 - METHOD FOR DIAGNOSING MALIGNANT TUMORS - Google Patents

METHOD FOR DIAGNOSING MALIGNANT TUMORS

Info

Publication number
FR2411412A1
FR2411412A1 FR7834749A FR7834749A FR2411412A1 FR 2411412 A1 FR2411412 A1 FR 2411412A1 FR 7834749 A FR7834749 A FR 7834749A FR 7834749 A FR7834749 A FR 7834749A FR 2411412 A1 FR2411412 A1 FR 2411412A1
Authority
FR
France
Prior art keywords
malignant tumors
lymphocytes
subject
migration
leucocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7834749A
Other languages
French (fr)
Other versions
FR2411412B3 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R & Z Vermoegensverw GmbH
Original Assignee
R & Z Vermoegensverw GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R & Z Vermoegensverw GmbH filed Critical R & Z Vermoegensverw GmbH
Publication of FR2411412A1 publication Critical patent/FR2411412A1/en
Application granted granted Critical
Publication of FR2411412B3 publication Critical patent/FR2411412B3/fr
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENTION A POUR OBJET UN PROCEDE DE TEST POUR LE DIAGNOSTIC DE TUMEURS MALIGNES. ELLE EST CARACTERISEE EN CE QUE LES LYMPHOCYTES A EXAMINER EN TANT QUE CONSTITUANTS CELLULAIRES DU SANG ET FAISANT PARTIE D'UNE SUSPENSION DE LEUCOCYTES SONT SOUMIS A UN TEST D'INHIBITION DE MIGRATION PENDANT LEQUEL LES LYMPHOCYTES SONT MIS EN CONTACT AVEC DES ANTIGENES FAVORISANT LA FORMATION DE FACTEURS D'INHIBITION DE MIGRATION (FIM) PUIS INCUBES, ET EN CE QU'ENSUITE LA MIGRATION DES LEUCOCYTES EST EMPECHEE ET ARRETEE PAR UN LAPS DE TEMPS PREDETERMINE. ELLE SE RAPPORTE AU DEPISTAGE DU CANCER.THE SUBJECT OF THE PRESENT INVENTION IS A TEST PROCESS FOR THE DIAGNOSIS OF MALIGNANT TUMORS. IT IS CHARACTERIZED IN THAT THE LYMPHOCYTES TO BE EXAMINED AS CELLULAR CONSTITUENTS OF BLOOD AND PART OF A LEUCOCYTE SUSPENSION ARE SUBJECT TO A MIGRATION INHIBITION TEST DURING WHICH THE LYMPHOCYTES ARE IN CONTACT WITH ANTIGATION. MIGRATION INHIBITION FACTORS (MIF) THEN INCUBATED, AND THEN LEUCOCYTE MIGRATION IS PREVENT AND STOPPED BY A PREDETERMINED TIME LAPS. IT RELATES TO SCREENING FOR CANCER.

FR7834749A 1977-12-12 1978-12-11 METHOD FOR DIAGNOSING MALIGNANT TUMORS Granted FR2411412A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2755363A DE2755363C3 (en) 1977-12-12 1977-12-12 Test method for diagnosing malignancies

Publications (2)

Publication Number Publication Date
FR2411412A1 true FR2411412A1 (en) 1979-07-06
FR2411412B3 FR2411412B3 (en) 1981-03-27

Family

ID=6025947

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7834749A Granted FR2411412A1 (en) 1977-12-12 1978-12-11 METHOD FOR DIAGNOSING MALIGNANT TUMORS

Country Status (25)

Country Link
JP (1) JPS54100176A (en)
AR (1) AR220356A1 (en)
AT (1) AT360178B (en)
AU (1) AU4234978A (en)
BE (1) BE872651A (en)
CA (1) CA1129319A (en)
CH (1) CH646793A5 (en)
DD (1) DD139903A5 (en)
DE (1) DE2755363C3 (en)
DK (1) DK532678A (en)
ES (2) ES475905A1 (en)
FI (1) FI783782A (en)
FR (1) FR2411412A1 (en)
GB (1) GB2009927B (en)
GR (1) GR66576B (en)
IL (1) IL56152A0 (en)
IT (1) IT1160323B (en)
LU (1) LU80609A1 (en)
NL (1) NL7811903A (en)
NO (1) NO784096L (en)
PL (1) PL112675B1 (en)
PT (1) PT68891A (en)
RO (1) RO75333A (en)
SE (1) SE432157B (en)
ZA (1) ZA786908B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436824A (en) * 1981-06-09 1984-03-13 Ortho Diagnostic Systems, Inc. Leukocyte migration through antigen containing agaroses for immunocompetence testing
JPH0672158B2 (en) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト Purified human macrophage migration inhibitory factor

Also Published As

Publication number Publication date
PT68891A (en) 1979-07-24
DD139903A5 (en) 1980-01-23
GB2009927B (en) 1982-10-06
DE2755363A1 (en) 1979-06-13
GR66576B (en) 1981-03-27
PL112675B1 (en) 1980-10-31
IT1160323B (en) 1987-03-11
SE432157B (en) 1984-03-19
DE2755363B2 (en) 1979-12-20
LU80609A1 (en) 1979-05-16
ES243564Y (en) 1980-12-16
ATA872478A (en) 1980-05-15
IL56152A0 (en) 1979-03-12
CA1129319A (en) 1982-08-10
IT7830722A0 (en) 1978-12-12
NL7811903A (en) 1979-06-14
FI783782A (en) 1979-06-13
JPS54100176A (en) 1979-08-07
DE2755363C3 (en) 1983-12-01
SE7812313L (en) 1979-06-13
ES475905A1 (en) 1979-10-16
RO75333A (en) 1980-11-30
BE872651A (en) 1979-03-30
AT360178B (en) 1980-12-29
ES243564U (en) 1980-06-01
ZA786908B (en) 1979-12-27
DK532678A (en) 1979-06-13
PL211672A1 (en) 1979-09-10
CH646793A5 (en) 1984-12-14
AR220356A1 (en) 1980-10-31
GB2009927A (en) 1979-06-20
FR2411412B3 (en) 1981-03-27
NO784096L (en) 1979-06-13
AU4234978A (en) 1979-06-21

Similar Documents

Publication Publication Date Title
Ruoslahti et al. Serum α-fetoprotein: diagnostic significance in liver disease
Abelev Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues
Enck et al. Tamoxifen treatment of metastatic breast cancer and antithrombin III levels
Golub et al. A modification of the hemolytic plaque assay for use with protein antigens
Banwo et al. New oncofetal antigen for human pancreas
Manni et al. The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency
ES8102726A1 (en) Diagnostic means, process for its preparation and its use in determining leucocytes in body fluids.
DE3750630T2 (en) Use of an antibody conjugate for the detection of necrotic malignant tissue and for the associated therapy.
Lechner A new type of coagulation inhibitor
DE2548636A1 (en) ANTISERIC AND ANTIBODIES WITH SPECIFIC EFFECT AGAINST CANCER CELL PROTEINS, THE PROCESS FOR THEIR PRODUCTION AND MEDICINAL PREPARATIONS
Thomson et al. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers
Campbell et al. Evans Blue disappearance rate in normal and pre-eclamptic pregnancy
Wada et al. Plasma level of tumor necrosis factor in disseminated intravascular coagulation
Cernosek et al. Prostaglandin F2α levels in peripheral sera of man
Gerfo et al. Tumor associated antigen with pulmonary neoplasms
US4202872A (en) Determination of heparin in blood plasma
DE69333076D1 (en) TESTING AND TREATING DEMYELINATING DISEASES LIKE MULTIPLE Sclerosis
ES2033823T3 (en) TRIAL AS TO HUMAN BREAST CANCER.
FR2411412A1 (en) METHOD FOR DIAGNOSING MALIGNANT TUMORS
DE2641840A1 (en) THROMBOSIS TEST
Bošnjaković et al. Radiolabelled anti-human fibrin antibody: a new thrombus-detecting agent
Lawford An abnormal serum component in experimental poisoning by cadmium and other metals
Wioland et al. Modifications of the thymocyte membrane during redistribution of concanavalin A receptors
ZA872145B (en) Method for the detection of pregnancy disorders
Vestergaard et al. Assessment of renal concentrating ability in lithium‐treated patients–COMPARISON OF LONG‐TERM DEHYDRATION WITH ADMINISTRATION OF A VASOPRESSIN ANALOGUE